Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
ASX Announcements
Filter by Year:
2024
2023
2022
2021
22-Dec-2023
Approval to commence dosing 3rd cohort of ISLA-101 SAD study
15-Dec-2023
R&D Tax Incentive loan facility secured with Radium Capital
12-Dec-2023
Second cohort dosed in ISLA-101 Single Ascending Dose study
1-Dec-2023
Company Secretary Appointment/Resignation
24-Nov-2023
Island doses first cohort in ISLA-101 clinical trial
16-Nov-2023
Replacement Constitution
16-Nov-2023
Replacement - Results of AGM
16-Nov-2023
Results of AGM
16-Nov-2023
Annual General Meeting MD Presentation
13-Nov-2023
Screening commences for ISLA-101 Single Ascending Dose Study
1
2
3
4
Next
.png){kind=logo}
